Health-focused venture studio, 2070 Health raised $30 million in seed funding from US-based venture capital firm W Health Ventures. The capital infusion will be used to develop the platform, expand the team, enhance the tech infrastructure, and serve as pre-seed capital for launching new startups in the healthtech sector.

CEO of 2070 Health, Pankaj Jethwani, revealed plans to invest in 15-20 startups over the next four to five years. The venture studio has already launched three startups and aims to introduce another company in the coming months. Jethwani stated that the focus will be on scaling these healthtech platforms from scratch, targeting a minimum addressable market of 100-300 million users and aiming to create solutions that are ten times better than existing products.

W Health President, Sunil Wadhwani, expressed the motivation behind their investment, stating, “We invested in 2070 Health to address these challenges that founders face while innovating in healthcare… we aim to impact the future of healthcare for one billion Indians over the next decade.”

2070 Health, founded in 2023, boasts a seasoned cross-functional team and a group of founders who evaluate numerous healthcare ideas to identify white spaces in the industry. The selected concepts undergo a validation process and are subjected to clinical studies and go-to-market experiments. Once the proposed solution is refined, a founding team is assembled, and playbooks covering clinical development, product, marketing, growth, and partnerships are implemented to propel the startups forward.

To navigate the complexities of the healthcare sector, 2070 Health maintains a dedicated team to oversee regulatory changes and compliance. The studio’s investment thesis focuses on two key areas: Indian startups building for the Indian market (Bharat) and Indian startups developing software-as-a-service (SaaS) products for global markets.

2070 Health has already introduced three startups as part of its first cohort, including ElevateNow, a weight loss startup; Nivaan Care, a tech-led pain management chain of clinics; and Reveal HealthTech, a healthtech SaaS platform.

Despite the challenging funding landscape and the recent slowdown in pandemic-era growth, the domestic healthtech ecosystem in India is poised for expansion. 2070 Health aims to tap into this thriving industry and contribute to its growth and development.

Health-focused venture studio, 2070 Health raised $30 million in seed funding from US-based venture capital firm W Health Ventures. The capital infusion will be used to develop the platform, expand the team, enhance the tech infrastructure, and serve as pre-seed capital for launching new startups in the healthtech sector.

CEO of 2070 Health, Pankaj Jethwani, revealed plans to invest in 15-20 startups over the next four to five years. The venture studio has already launched three startups and aims to introduce another company in the coming months. Jethwani stated that the focus will be on scaling these healthtech platforms from scratch, targeting a minimum addressable market of 100-300 million users and aiming to create solutions that are ten times better than existing products.

W Health President, Sunil Wadhwani, expressed the motivation behind their investment, stating, “We invested in 2070 Health to address these challenges that founders face while innovating in healthcare… we aim to impact the future of healthcare for one billion Indians over the next decade.”

2070 Health, founded in 2023, boasts a seasoned cross-functional team and a group of founders who evaluate numerous healthcare ideas to identify white spaces in the industry. The selected concepts undergo a validation process and are subjected to clinical studies and go-to-market experiments. Once the proposed solution is refined, a founding team is assembled, and playbooks covering clinical development, product, marketing, growth, and partnerships are implemented to propel the startups forward.

To navigate the complexities of the healthcare sector, 2070 Health maintains a dedicated team to oversee regulatory changes and compliance. The studio’s investment thesis focuses on two key areas: Indian startups building for the Indian market (Bharat) and Indian startups developing software-as-a-service (SaaS) products for global markets.

2070 Health has already introduced three startups as part of its first cohort, including ElevateNow, a weight loss startup; Nivaan Care, a tech-led pain management chain of clinics; and Reveal HealthTech, a healthtech SaaS platform.

Despite the challenging funding landscape and the recent slowdown in pandemic-era growth, the domestic healthtech ecosystem in India is poised for expansion. 2070 Health aims to tap into this thriving industry and contribute to its growth and development.